TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
129.71
-2.74 (-2.07%)
Oct 28, 2025, 4:00 PM EDT - Market closed
TransMedics Group Revenue
TransMedics Group had revenue of $157.37M in the quarter ending June 30, 2025, with 37.68% growth. This brings the company's revenue in the last twelve months to $531.29M, up 48.09% year-over-year. In the year 2024, TransMedics Group had annual revenue of $441.54M with 82.74% growth.
Revenue (ttm)
$531.29M
Revenue Growth
+48.09%
P/S Ratio
8.22
Revenue / Employee
$729,797
Employees
728
Market Cap
4.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 441.54M | 199.92M | 82.74% |
| Dec 31, 2023 | 241.62M | 148.16M | 158.53% |
| Dec 31, 2022 | 93.46M | 63.20M | 208.83% |
| Dec 31, 2021 | 30.26M | 4.62M | 18.03% |
| Dec 31, 2020 | 25.64M | 2.04M | 8.62% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
TMDX News
- 13 days ago - TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025 - PRNewsWire
- 5 weeks ago - TransMedics: I'm More Bullish Than Ever - Seeking Alpha
- 5 weeks ago - TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy - PRNewsWire
- 6 weeks ago - TransMedics: Upcoming Trials Are Critical - Seeking Alpha
- 7 weeks ago - TransMedics Group, Inc. (TMDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - TransMedics: Just Like The CEO, I'm Buying - Seeking Alpha
- 2 months ago - TransMedics to Present at Upcoming September Investor Conferences - PRNewsWire
- 2 months ago - TransMedics: CEO Is Buying Shares Ahead Of A Potentially Concerning Q3 - Seeking Alpha